erythrosine has been researched along with Huntington Disease in 5 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used a murine model of Huntington's disease, the R6/2 transgenic mouse, and in vivo bromodeoxyuridine administration to label cells undergoing proliferation and to follow their migration along the rostral migratory stream." | 1.35 | Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model. ( de Castro Batista, CM; de Moraes Mello, LE; Mendez-Otero, R; Moraes, L; Shimabukuro, MK, 2009) |
| "Prion diseases are associated with the misfolding of the host-encoded cellular prion protein (PrP(C)) into a disease associated form (PrP(Sc))." | 1.35 | Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence. ( Cappai, R; Coleman, BM; Han, S; Hatters, DM; Hill, AF; Nisbet, RM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moraes, L | 1 |
| de Moraes Mello, LE | 1 |
| Shimabukuro, MK | 1 |
| de Castro Batista, CM | 1 |
| Mendez-Otero, R | 1 |
| Coleman, BM | 1 |
| Nisbet, RM | 1 |
| Han, S | 1 |
| Cappai, R | 1 |
| Hatters, DM | 1 |
| Hill, AF | 1 |
| Suopanki, J | 1 |
| Götz, C | 1 |
| Lutsch, G | 1 |
| Schiller, J | 1 |
| Harjes, P | 1 |
| Herrmann, A | 1 |
| Wanker, EE | 1 |
| Winkler, C | 1 |
| Gil, JM | 1 |
| Araújo, IM | 1 |
| Riess, O | 1 |
| Skripuletz, T | 1 |
| von Hörsten, S | 1 |
| Petersén, A | 1 |
| Lee, ST | 1 |
| Park, JE | 1 |
| Kim, DH | 1 |
| Kim, S | 1 |
| Im, WS | 1 |
| Kang, L | 1 |
| Jung, SH | 1 |
| Kim, MW | 1 |
| Chu, K | 1 |
| Kim, M | 1 |
5 other studies available for erythrosine and Huntington Disease
| Article | Year |
|---|---|
Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model.
Topics: Animals; Apoptosis; Brain; Bromodeoxyuridine; Cell Movement; Disease Models, Animal; Female; Fluores | 2009 |
Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Topics: Alzheimer Disease; Animals; Cysteine; Fluoresceins; Fluorescence; Huntington Disease; Luminescent Me | 2009 |
Interaction of huntingtin fragments with brain membranes--clues to early dysfunction in Huntington's disease.
Topics: Age Factors; Animals; Blotting, Western; Brain; Brain Chemistry; Disease Models, Animal; Fluorescein | 2006 |
Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Brain; Disease Models, Animal; Fluores | 2006 |
Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Drug Interactions; Fluoresceins; Gene Expression R | 2008 |